Seroquel® (ICI 204 636): A novel, atypical antipsychotic: Efficacy and safety results from two phase II, multicenter, placebocontrolled clinical trials

Seroquel® (ICI 204 636): A novel, atypical antipsychotic: Efficacy and safety results from two phase II, multicenter, placebocontrolled clinical trials

Saved in:
Bibliographic Details
Published in:Schizophrenia research Vol. 15; no. 1; p. 142
Main Authors: Arvanitis, Lisa, Miller, Barbara G., Link, Chris G.G.
Format: Journal Article
Language:English
Published: Elsevier B.V 01-04-1995
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Author Miller, Barbara G.
Link, Chris G.G.
Arvanitis, Lisa
Author_xml – sequence: 1
  givenname: Lisa
  surname: Arvanitis
  fullname: Arvanitis, Lisa
– sequence: 2
  givenname: Barbara G.
  surname: Miller
  fullname: Miller, Barbara G.
– sequence: 3
  givenname: Chris G.G.
  surname: Link
  fullname: Link, Chris G.G.
BookMark eNp9kMFq3DAQhkVJoJu0b9CDjgms05EtyascCmFJE7OBHNqehSyPiIrWciUlxW_Sp-hD9MniTUqPPf3wz_z_DN8JORrjiIR8YHDBgMmPoGqolJL8TIlzJTiHaveGrJhom6oWoI7I6t_KW3KS83cAYALaFfn1BVP88Yjhz2961m07WgOnspHnl_SKjvEJw5qaMk_emkDNWPyUZ_sQi7eX9Nq5xbbz4g80G4dlpgnzYyiZuhT3tPyMdHowGWnXrel-GXiLY8G0plMwFvto41hSDAEHaoMfX66U5E3I78ixWwTf_9VT8u3z9dftbXV3f9Ntr-4qywTbVdwy6B0IYaHvJXNtzxjWrYBaKo5S9XYzyEHJhgO2joFzTKi-2XC3GbgRrjkl_LXXpphzQqen5PcmzZqBPtDVB3T6gE4roV_o6t0S-_Qaw-W3J49JZ-txtDj4hLboIfr_FzwDUR-Elg
CitedBy_id crossref_primary_10_1002_14651858_CD012397_pub2
crossref_primary_10_1016_S0924_9338_97_89486_2
ContentType Journal Article
Copyright 1995
Copyright_xml – notice: 1995
CorporateAuthor US and International SEROQUEL Study Groups
CorporateAuthor_xml – name: US and International SEROQUEL Study Groups
DBID AAYXX
CITATION
DOI 10.1016/0920-9964(95)95440-K
DatabaseName CrossRef
DatabaseTitle CrossRef
DeliveryMethod fulltext_linktorsrc
EISSN 1573-2509
EndPage 142
ExternalDocumentID 10_1016_0920_9964_95_95440_K
092099649595440K
GroupedDBID ---
--K
--M
-~X
.1-
.FO
.GJ
.~1
0R~
123
1B1
1P~
1RT
1~.
1~5
4.4
457
4G.
4H-
53G
5VS
7-5
71M
8P~
9JM
9JO
AABNK
AACTN
AADFP
AADPK
AAEDT
AAEDW
AAGJA
AAGUQ
AAIAV
AAIKJ
AAKOC
AALRI
AAOAW
AAQFI
AAQXK
AAWTL
AAXLA
AAXUO
ABBQC
ABCQJ
ABFNM
ABIVO
ABJNI
ABLVK
ABMAC
ABMZM
ABOYX
ABXDB
ABYKQ
ACDAQ
ACGFS
ACHQT
ACIUM
ACRLP
ACXNI
ADBBV
ADEZE
ADMUD
AEBSH
AEKER
AENEX
AEVXI
AFCTW
AFKWA
AFRHN
AFTJW
AFXIZ
AFYLN
AGHFR
AGUBO
AGWIK
AGYEJ
AHHHB
AIEXJ
AIKHN
AITUG
AJBFU
AJOXV
AJRQY
AJUYK
ALMA_UNASSIGNED_HOLDINGS
AMFUW
AMRAJ
ANZVX
ASPBG
AVWKF
AXJTR
AZFZN
BKOJK
BLXMC
BNPGV
CS3
DU5
EBS
EFJIC
EFLBG
EJD
EO8
EO9
EP2
EP3
F5P
FDB
FEDTE
FGOYB
FIRID
FNPLU
FYGXN
G-2
G-Q
GBLVA
HEG
HMK
HMO
HMQ
HMW
HVGLF
HZ~
IHE
J1W
KOM
LCYCR
M29
M2V
M39
M3V
M41
MO0
MOBAO
N9A
O-L
O9-
OAUVE
OH0
OKEIE
OU-
OZT
P-8
P-9
P2P
PC.
Q38
R2-
RIG
ROL
RPZ
SAE
SCC
SDF
SDG
SDP
SEL
SES
SEW
SNS
SPCBC
SPS
SSB
SSH
SSN
SSY
SSZ
T5K
WUQ
Z5R
~G-
AAXKI
AAYXX
AFJKZ
AKRWK
CITATION
ID FETCH-LOGICAL-c151K-4c10bf055c0bb61f7b11e27502694e69bc8d6d96340e7f10ff159b384f8d4a5f3
ISSN 0920-9964
IngestDate Thu Sep 26 19:24:35 EDT 2024
Fri Feb 23 02:30:52 EST 2024
IsPeerReviewed true
IsScholarly true
Issue 1
Language English
LinkModel OpenURL
MergedId FETCHMERGED-LOGICAL-c151K-4c10bf055c0bb61f7b11e27502694e69bc8d6d96340e7f10ff159b384f8d4a5f3
PageCount 1
ParticipantIDs crossref_primary_10_1016_0920_9964_95_95440_K
elsevier_sciencedirect_doi_10_1016_0920_9964_95_95440_K
PublicationCentury 1900
PublicationDate 1995-4-00
PublicationDateYYYYMMDD 1995-04-01
PublicationDate_xml – month: 04
  year: 1995
  text: 1995-4-00
PublicationDecade 1990
PublicationTitle Schizophrenia research
PublicationYear 1995
Publisher Elsevier B.V
Publisher_xml – name: Elsevier B.V
SSID ssj0001507
Score 1.4997048
SourceID crossref
elsevier
SourceType Aggregation Database
Publisher
StartPage 142
Title Seroquel® (ICI 204 636): A novel, atypical antipsychotic: Efficacy and safety results from two phase II, multicenter, placebocontrolled clinical trials
URI https://dx.doi.org/10.1016/0920-9964(95)95440-K
Volume 15
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://sdu.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV3dbtMwFLa67YYbNASIMUDnAqRNaSBu7aTeXTUCC0XcbEi7i5I40SpNbUXaTbwJT8FD8GScYzs_UxECJG6i1nEcJefL8Xfs88PYyxKpUIbEAb80Lnwi7H6Wc-5rtFjQJsqFNt7uZ-fRp8vJ21jEg0FTvK5r-6-SxjaUNUXO_oW020GxAX-jzPGIUsfjH8kdP37S9cgZR6-msSGQp4k3CoQXUlkVZUPRF8sbuz2frb-uXMKA9dyFZM3paajmMp4obH6mOqvItxNt8831unZBKbdLb3WFs6CXJDSU8U0kZ0-LAuPtlS-dL_w1Ets2CtOUCqn7vPi87_vnuQxEVx0abyhLh02H8HFet1NJF8no9k28969bFyO0stv0CdjuzmgX8id7jjFm2W0r9MauX6Ldi8aaXY0onfaOxj5yOnVHvcstGFtdzW1aLzftu39bM4pd3GjvhlJTEoWlJG2Kz7pZtPVtpK7UU0nTZ7bD9kaoBFEH702T-PJDyxOIiptMkG7oJrCTh2_atiMlj92tfk2cemToYp_dd1YMTC38HrBBuXjIvjXQ-_EdjhB0gKADBN3xCUzBAG4IDdzgDtxOoAEbtmuwYAMHNiCwAYINDNggSYbQg9oQtoAGDdDAAu0R-_wuvjg9813hD79AAjrzRcGDvAqkLII8D3kVofYoqRABhV2XocqLiQ41Th0iKKOKB1WFpDwfT0Q10SKT1fgx210sF-UTBpUqCjHSBUqAqmznKphorrmKMrIccnHA_Oatpiub3yVtHB9JCilJIVUyNVJIZwcsal596jiq5Z4pAua3Vz795ysP2b3us3jGdtdfNuVztlPrzQuHqZ81C6zr
link.rule.ids 315,782,786,27933,27934
linkProvider Elsevier
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Seroquel%C2%AE+%28ICI+204+636%29%3A+A+novel%2C+atypical+antipsychotic%3A+Efficacy+and+safety+results+from+two+phase+II%2C+multicenter%2C+placebocontrolled+clinical+trials&rft.jtitle=Schizophrenia+research&rft.au=Arvanitis%2C+Lisa&rft.au=Miller%2C+Barbara+G.&rft.au=Link%2C+Chris+G.G.&rft.date=1995-04-01&rft.pub=Elsevier+B.V&rft.issn=0920-9964&rft.eissn=1573-2509&rft.volume=15&rft.issue=1&rft.spage=142&rft.epage=142&rft_id=info:doi/10.1016%2F0920-9964%2895%2995440-K&rft.externalDocID=092099649595440K
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0920-9964&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0920-9964&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0920-9964&client=summon